About

Bridging the Gap Between Science and Solutions

Welcome to The Naeger Group, a pioneering force in the field of translational medicine. We stand at the forefront of innovation, dedicating our efforts to transforming scientific discoveries into tangible, patentable products that revolutionize the drug industry.

A Visionary Leader in Translational Medicine

At the helm of our endeavors is David M. Naeger, a visionary inventor and the founder of The Naeger Group. David’s expertise and passion for translational science have led to the creation of groundbreaking medical solutions. His unique approach to medicine development has established him as a leading figure in the pharmaceutical world.

Exclusive Partnership Opportunities

We understand the dynamic and competitive nature of the pharmaceutical industry. That’s why we offer exclusive partnership opportunities to two or three industry leaders. Our goal is to collaborate with you in developing products that align with your strategic therapeutic areas. By working together, we can unlock new potentials and create solutions that matter.

Areas of Specialization

Our focus is on developing translational medicine products in key therapeutic areas, including:

Appetite Suppression: Addressing the global challenge of obesity and related health issues with innovative approaches.
Addiction Control: Providing breakthrough solutions in the fight against various forms of addiction.
Type Two Diabetes: Tackling one of the most prevalent chronic diseases with novel therapeutic options.
Virology: Advancing antiviral treatments to combat emerging and existing viral threats.

Advancing Beyond Traditional Approaches

Our approach is inspired by the promising results of GLP-1 agonists but goes beyond their limitations. We strive to create translational medicine products that offer similar benefits without the broad multi-organ systemic effects associated with treatments like Ozempic, Wegovy, Mounjaro, Zepbound, etc. This innovative direction not only enhances the efficacy of treatments but also reduces potential side effects, providing a more patient-friendly solution.